AU1868692A - Benzomorphan derivatives - Google Patents
Benzomorphan derivativesInfo
- Publication number
- AU1868692A AU1868692A AU18686/92A AU1868692A AU1868692A AU 1868692 A AU1868692 A AU 1868692A AU 18686/92 A AU18686/92 A AU 18686/92A AU 1868692 A AU1868692 A AU 1868692A AU 1868692 A AU1868692 A AU 1868692A
- Authority
- AU
- Australia
- Prior art keywords
- alkyl
- acyl
- aryl
- benzomorphan derivatives
- alkynyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/22—Bridged ring systems
- C07D221/26—Benzomorphans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Cardiology (AREA)
- Psychiatry (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
Abstract
Benzomorphane derivs. of formula (I) are new. In (I), X = O or S; R1 = 1-8C alkyl, 3-6C alkenyl, 3-6C alkynyl or aryl; R2 = H, 1-8C alkyl, 3-6C alkenyl, 3-6C alkynyl, aryl or aralkyl; R3 = H or 1-6C alkyl; R4 and R5 = each 1-8C alkyl; R6 = 1-8C alkyl or aryl; R7 and R8 = each H, 1-8C alkyl, halogen, OH, 1-8C alkoxy, O-Acyl, CN, NO2, NH2, NH(1-8C alkyl), N(1-8C alkyl)2 (n which the alkyl gps. are opt. different), NH-acyl or N-acyl-(1-8C alkyl).
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4121821A DE4121821A1 (en) | 1991-07-02 | 1991-07-02 | NEW BENZOMORPHANE AND ITS USE AS A MEDICAMENT |
DE4121821 | 1991-07-02 |
Publications (2)
Publication Number | Publication Date |
---|---|
AU1868692A true AU1868692A (en) | 1993-01-07 |
AU657330B2 AU657330B2 (en) | 1995-03-09 |
Family
ID=6435223
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU18686/92A Expired AU657330B2 (en) | 1991-07-02 | 1992-06-30 | Benzomorphan derivatives |
Country Status (24)
Country | Link |
---|---|
EP (1) | EP0521422B1 (en) |
JP (1) | JP3324785B2 (en) |
KR (1) | KR100251256B1 (en) |
AT (1) | ATE137749T1 (en) |
AU (1) | AU657330B2 (en) |
CA (1) | CA2072814C (en) |
CZ (1) | CZ286949B6 (en) |
DE (2) | DE4121821A1 (en) |
DK (1) | DK0521422T3 (en) |
ES (1) | ES2086585T3 (en) |
FI (1) | FI105913B (en) |
GR (1) | GR3020124T3 (en) |
HK (1) | HK1003111A1 (en) |
HU (1) | HU220873B1 (en) |
IE (1) | IE74400B1 (en) |
IL (1) | IL102361A (en) |
MX (1) | MX9203845A (en) |
NO (1) | NO178263C (en) |
NZ (1) | NZ243388A (en) |
PH (1) | PH31430A (en) |
SG (1) | SG43001A1 (en) |
SK (1) | SK280776B6 (en) |
TW (1) | TW214547B (en) |
ZA (1) | ZA924883B (en) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19528472A1 (en) * | 1995-08-03 | 1997-02-06 | Boehringer Ingelheim Kg | New process for the production of norbenzomorphan of an intermediate stage in the production of pharmaceutically valuable benzomorphan derivatives, in particular of (-) - (1R, 5S, S "R) -3'-hydroxy-2- (2-methoxypropyl -) - 5.9.9 -trimethyl-6.7 benzomorphan |
DE19740110A1 (en) | 1997-09-12 | 1999-03-18 | Boehringer Ingelheim Pharma | New hydroxy substituted benzomorphan derivatives |
JPH1196519A (en) * | 1997-09-17 | 1999-04-09 | Alps Electric Co Ltd | Spin valve type thin-film element and its production |
US6136980A (en) * | 1998-05-01 | 2000-10-24 | Boehringer Ingelheim Kg | Method of preparing norbenzomorphane as an intermediate in the preparation of pharmaceutically useful benzomorphane derivatives, in particular (-)-(1R,5S,2"R)-3'-hydroxy-2-(2-methoxypropyl)-5,9,9-trimethyl-6,7-benzo morphane |
DE19826365A1 (en) * | 1998-06-12 | 1999-12-16 | Gruenenthal Gmbh | Use of benzomorphan derivatives as an analgesic |
US6355652B1 (en) | 1999-11-27 | 2002-03-12 | Boehringer Ingelheim Pharma Kg | Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocines and their use as pharmaceutical compositions |
DE19957156A1 (en) * | 1999-11-27 | 2001-05-31 | Boehringer Ingelheim Pharma | New amino and fluoro substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocine derivatives useful in treatment of e.g. arrythmias, spasms, ischaemia, pain and neurodegenerative disorders |
DE10204276A1 (en) * | 2002-02-02 | 2003-08-07 | Boehringer Ingelheim Pharma | N-Allyloxyethyl-1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocines and their use as pharmaceuticals |
US7501433B2 (en) | 2002-05-17 | 2009-03-10 | Jenken Biosciences, Inc. | Opioid and opioid-like compounds and uses thereof |
JP5438250B2 (en) | 2002-05-17 | 2014-03-12 | ジェンケン バイオサイエンスィズ,インコーポレイテッド | Opioids and opioid-like compounds and their use |
US7923454B2 (en) | 2002-05-17 | 2011-04-12 | Jenken Biosciences, Inc. | Opioid and opioid-like compounds and uses thereof |
US8017622B2 (en) | 2003-05-16 | 2011-09-13 | Jenken Biosciences, Inc. | Opioid and opioid-like compounds and uses thereof |
EP2220048B1 (en) * | 2007-11-16 | 2017-01-25 | Boehringer Ingelheim International GmbH | Aryl- and heteroarylcarbonyl derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use |
WO2015097545A1 (en) | 2013-12-26 | 2015-07-02 | Purdue Pharma L.P. | Opioid receptor modulating oxabicyclo[2.2.2]octane morphinans |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL7804509A (en) * | 1978-04-26 | 1979-10-30 | Acf Chemiefarma Nv | Novel 6,7-benzomorphan derivatives and their acid addition salts. |
DE2828039A1 (en) * | 1978-06-26 | 1980-01-10 | Boehringer Sohn Ingelheim | 2- (2-ALKOXYETHYL) -2'-HYDROXY-6,7-BENZOMORPHANES THEIR ACID ADDITION SALTS, THESE MEDICINAL PRODUCTS, AND METHOD FOR THE PRODUCTION THEREOF |
NL7907800A (en) * | 1979-10-23 | 1981-04-27 | Acf Chemiefarma Nv | Novel 6,7-benzomorphan derivatives and their acid addition salts, pharmaceutical compositions containing such a compound, and process for the preparation of these compounds and their pharmaceutical compositions. |
-
1991
- 1991-07-02 DE DE4121821A patent/DE4121821A1/en not_active Withdrawn
-
1992
- 1992-06-03 TW TW081104377A patent/TW214547B/zh not_active IP Right Cessation
- 1992-06-27 SG SG1996002082A patent/SG43001A1/en unknown
- 1992-06-27 DE DE59206212T patent/DE59206212D1/en not_active Expired - Lifetime
- 1992-06-27 AT AT92110923T patent/ATE137749T1/en active
- 1992-06-27 ES ES92110923T patent/ES2086585T3/en not_active Expired - Lifetime
- 1992-06-27 EP EP92110923A patent/EP0521422B1/en not_active Expired - Lifetime
- 1992-06-27 DK DK92110923.7T patent/DK0521422T3/en active
- 1992-06-30 MX MX9203845A patent/MX9203845A/en unknown
- 1992-06-30 AU AU18686/92A patent/AU657330B2/en not_active Expired
- 1992-06-30 CA CA002072814A patent/CA2072814C/en not_active Expired - Lifetime
- 1992-06-30 IL IL10236192A patent/IL102361A/en not_active IP Right Cessation
- 1992-06-30 NZ NZ243388A patent/NZ243388A/en not_active IP Right Cessation
- 1992-07-01 ZA ZA924883A patent/ZA924883B/en unknown
- 1992-07-01 NO NO922603A patent/NO178263C/en not_active IP Right Cessation
- 1992-07-01 JP JP17447992A patent/JP3324785B2/en not_active Expired - Lifetime
- 1992-07-01 FI FI923050A patent/FI105913B/en not_active IP Right Cessation
- 1992-07-01 KR KR1019920011664A patent/KR100251256B1/en not_active IP Right Cessation
- 1992-07-01 HU HU9202199A patent/HU220873B1/en unknown
- 1992-07-01 IE IE922144A patent/IE74400B1/en not_active IP Right Cessation
- 1992-07-02 CZ CS19922075A patent/CZ286949B6/en not_active IP Right Cessation
- 1992-07-02 SK SK2075-92A patent/SK280776B6/en not_active IP Right Cessation
- 1992-07-02 PH PH44606A patent/PH31430A/en unknown
-
1996
- 1996-05-31 GR GR960401503T patent/GR3020124T3/en unknown
-
1998
- 1998-03-16 HK HK98102148A patent/HK1003111A1/en not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU1868692A (en) | Benzomorphan derivatives | |
LU92544I2 (en) | Ezetimibe in combination with rosuvastatin or pharmaceutically acceptable salts, including rosuvastatin in the form of zinc salt | |
HU9904389D0 (en) | Pyridine carboxylic acid derivatives and their salts, antibacterial agent comrising the same | |
MX9805181A (en) | Lactone derivatives of 17.beta.-carboxy, carbothio and amide androstane derivatives. | |
FI941324A (en) | 10 desasetoksitaksolijohdannaisia | |
NO912940D0 (en) | IMMUNE REPRESENTATIVE AGENT AND PROCEDURE FOR PREPARING THE SAME. | |
AU1227795A (en) | Cosmetic or pharmaceutical compositions consisting of liposomes | |
YU12992A (en) | 2-AMINO-1,2,3,4, -TETRAHYDRONAPHTHALENE SUBSTITUTED IN THE RING | |
NO961356D0 (en) | Anthracycline derivatives, and their use in amyloidosis | |
DE69701301D1 (en) | Substituted benzyl derivatives of polyalkylene polyamines and their use in cosmetic and pharmaceutical compositions | |
ES2158809A1 (en) | New phenylsulfonate compounds are cyclooxygenase II inhibitors used for treating e.g. inflammation and Alzheimer's disease |